Literature DB >> 9166471

VHL gene mutation and clear-cell renal carcinomas.

A G Knudson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9166471

Source DB:  PubMed          Journal:  Cancer J Sci Am        ISSN: 1081-4442


× No keyword cloud information.
  7 in total

1.  The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.

Authors:  A Pause; S Lee; R A Worrell; D Y Chen; W H Burgess; W M Linehan; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 2.  The not-so-sweet side of sugar: Influence of the microenvironment on the processes that unleash cancer.

Authors:  Mam Y Mboge; Mina J Bissell
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-09       Impact factor: 6.633

Review 3.  Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma.

Authors:  Zofia Felicja Bielecka; Anna Małgorzata Czarnecka; Cezary Szczylik
Journal:  Front Oncol       Date:  2014-07-25       Impact factor: 6.244

4.  Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.

Authors:  M Yoshida; S Ashida; K Kondo; K Kobayashi; H Kanno; N Shinohara; N Shitara; T Kishida; S Kawakami; M Baba; I Yamamoto; M Hosaka; T Shuin; M Yao
Journal:  Jpn J Cancer Res       Date:  2000-02

5.  Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics.

Authors:  W Marston Linehan
Journal:  Genome Res       Date:  2012-10-04       Impact factor: 9.043

Review 6.  Early identification of patients with von Hippel-Lindau disease at risk for pheochromocytoma.

Authors:  J K Maranchie; M M Walther
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

7.  Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels.

Authors:  Mei Yi Sim; Hung Huynh; Mei Lin Go; John Shyi Peng Yuen
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.